Phase I Study to Assess the Safety and Immunogenicity of an Intradermal COVID-19 DNA Vaccine Administered Using a Pyro-Drive Jet Injector in Healthy Adults.
Nakagami H, Hayashi H, Sun J, Yanagida Y, Otera T, Nakagami F, Hamaguchi S, Yoshida H, Okuno H, Yoshida S, Nakamaru R, Yokoyama S, Fujimoto T, Hongyo K, Akeda Y, Morishita R, Tomono K, Rakugi H.
Nakagami H, et al. Among authors: okuno h.
Vaccines (Basel). 2022 Aug 30;10(9):1427. doi: 10.3390/vaccines10091427.
Vaccines (Basel). 2022.
PMID: 36146505
Free PMC article.